Godavari Drugs Limited (BOM:530317)
77.27
+1.67 (2.21%)
At close: Mar 5, 2026
Godavari Drugs Market Cap
Godavari Drugs has a market cap or net worth of 581.88 million as of March 5, 2026. Its market cap has decreased by -20.67% in one year.
Market Cap
581.88M
Enterprise Value
1.30B
Revenue
986.94M
Ranking
n/a
PE Ratio
15.74
Stock Price
77.27
Market Cap Chart
Since April 30, 2001, Godavari Drugs's market cap has increased from 15.34M to 581.88M, an increase of 3,692.48%. That is a compound annual growth rate of 15.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 581.88M | 0.57% |
| Dec 31, 2025 | 578.57M | -29.74% |
| Dec 31, 2024 | 823.46M | 21.42% |
| Dec 29, 2023 | 678.20M | -5.10% |
| Dec 30, 2022 | 714.64M | 51.48% |
| Dec 31, 2021 | 471.79M | 79.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accretion Pharmaceuticals | 756.44M |
| Asston Pharmaceuticals | 681.04M |
| Amwill Health Care | 669.12M |
| Onyx Biotec | 612.87M |
| Phaarmasia | 561.65M |
| Shelter Pharma | 540.78M |
| Biofil Chemicals and Pharmaceuticals | 494.72M |
| Mangalam Drugs & Organics | 442.87M |